<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02558231</url>
  </required_header>
  <id_info>
    <org_study_id>AC-065A308</org_study_id>
    <nct_id>NCT02558231</nct_id>
  </id_info>
  <brief_title>The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial Hypertension</brief_title>
  <acronym>TRITON</acronym>
  <official_title>The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial Hypertension: A Multi-center, Double-blind, Placebo-controlled, Phase 3b Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Actelion</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Actelion</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this clinical trial is to compare the efficacy and safety of an initial
      triple oral treatment regimen (macitentan, tadalafil, selexipag) versus an initial dual oral
      treatment regimen (macitentan, tadalafil, placebo) in newly diagnosed, treatment-naïve
      patients with pulmonary arterial hypertension.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2016</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pulmonary vascular resistance</measure>
    <time_frame>Baseline to Week 26</time_frame>
    <description>As measured by right heart catheterization</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">238</enrollment>
  <condition>Pulmonary Arterial Hypertension</condition>
  <arm_group>
    <arm_group_label>Triple oral combination treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Macitentan, tadalafil, and selexipag</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dual oral combination treatment</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Macitentan, tadalafil, and placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Macitentan</intervention_name>
    <description>Used open-label in both arms, 10 mg tablet, 1 tablet u.i.d.</description>
    <arm_group_label>Triple oral combination treatment</arm_group_label>
    <arm_group_label>Dual oral combination treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tadalafil</intervention_name>
    <description>Used open-label in both arms, 20 mg tablet, 1-2 tablets u.i.d.</description>
    <arm_group_label>Triple oral combination treatment</arm_group_label>
    <arm_group_label>Dual oral combination treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Selexipag</intervention_name>
    <description>Used double-blind in the triple oral treatment arm, 200 microgram tablet, 1-8 tablets b.i.d.</description>
    <arm_group_label>Triple oral combination treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Signed informed consent prior to any study-mandated procedure.

          2. Male or female ≥ 18 and ≤ 75 years of age at screening.

          3. Initial PAH diagnosis &lt; 6 months prior to enrollment.

          4. RHC performed between Day −28 and Day 1, meeting all the following criteria:

               -  Mean pulmonary artery pressure (mPAP) ≥ 25 mmHg.

               -  Pulmonary artery wedge pressure or left ventricular end-diastolic pressure ≤ 15
                  mmHg.

               -  PVR ≥ 480 dyn•sec/cm5 (≥ 6 Wood Units).

               -  Negative vasoreactivity test mandatory in idiopathic, heritable, and drug/toxin
                  induced PAH (at this or a previous RHC).

          5. Symptomatic PAH belonging to one of the following subgroups:

               -  Idiopathic.

               -  Heritable.

               -  Drug or toxin induced.

               -  Associated with one of the following: connective tissue disease; HIV infection;
                  congenital heart disease.

          6. 6-minute walk distance (6MWD) ≥ 50 m at screening.

          7. Women of childbearing potential must not be pregnant, must perform regular pregnancy
             tests, and use reliable contraception.

        Exclusion Criteria:

          1. Any PAH-specific drug therapy at any time.

          2. Cardio pulmonary rehabilitation program based on exercise (planned, or started ≤ 12
             weeks prior to Day 1).

          3. Body mass index (BMI) &gt; 40 kg/m2 at screening.

          4. Presence of three or more of the following risk factors for heart failure with
             preserved ejection fraction at screening:

               -  BMI &gt; 30 kg/m2.

               -  Diabetes mellitus of any type.

               -  Essential hypertension.

               -  Coronary artery disease, i.e., any of the following:

                    -  History of stable angina or

                    -  More than 50% stenosis in a coronary artery (by coronary angiography) or

                    -  History of myocardial infarction or

                    -  History of or planned coronary artery bypass grafting and/or coronary artery
                       stenting.

          5. Acute myocardial infarction ≤ 12 weeks prior to screening.

          6. Stroke ≤ 12 weeks prior to screening.

          7. Known permanent atrial fibrillation.

          8. SBP &lt; 90 mmHg at screening or Day 1.

          9. Ongoing or planned treatment with organic nitrates and/or doxazosin.

         10. Presence of one or more of the following signs of relevant lung disease at any time up
             to screening:

               -  Diffusing capacity of the lung for carbon monoxide (DLCO) &lt; 40% of predicted
                  (eligible only if no or mild interstitial lung disease on computed tomography).

               -  Forced vital capacity (FVC) &lt; 60% of predicted.

               -  Forced expiratory volume in one second (FEV1) &lt; 60% of predicted.

         11. Known or suspected pulmonary veno-occlusive disease (PVOD).

         12. Documented severe hepatic impairment (with or without cirrhosis) according to National
             Cancer Institute organ dysfunction working group criteria, defined as total bilirubin
             &gt; 3 × upper limit of the normal range (ULN) accompanied by aspartate aminotransferase
             (AST) &gt; ULN (assessed by central laboratory at screening); and/or Child-Pugh Class C.

         13. Serum AST and/or alanine aminotransferase (ALT) &gt; 3 × ULN (assessed by central
             laboratory at screening).

         14. Severe renal impairment (estimated creatinine clearance ≤ 30 mL/min/1.73 m2) assessed
             by central laboratory at screening.

         15. Ongoing or planned dialysis.

         16. Hemoglobin &lt; 100 g/L assessed by central laboratory at screening.

         17. Known or suspected uncontrolled thyroid disease (hypo- or hyperthyroidism).

         18. Loss of vision in one or both eyes because of non-arteritic ischemic optic neuropathy
             (NAION).

         19. Treatment with strong inducers of cytochrome P450 3A4 (CYP3A4; e.g., carbamazepine,
             rifampin, rifampicin, rifabutin, rifapentin, phenobarbital, phenytoin, and St. John's
             wort) ≤ 28 days prior to Day 1.

         20. Treatment with strong inhibitors of CYP3A4 (e.g., ketoconazole, itraconazole,
             voriconazole, clarithromycin, telithromycin, nefazodone, ritonavir, and saquinavir)
             and/or strong inhibitors of CYP2C8 (e.g., gemfibrozil) ≤ 28 days prior to Day 1.

         21. Treatment with another investigational drug (planned, or taken ≤ 12 weeks prior to Day
             1).

         22. Hypersensitivity to any of the 3 study treatments or any excipient of their
             formulations.

         23. Pregnancy, breastfeeding, or intention to become pregnant during the study.

         24. Concomitant life-threatening disease with a life expectancy &lt; 12 months.

         25. Alcohol abuse.

         26. Any factor or condition likely to affect protocol compliance of the subject, as judged
             by the investigator.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Loic Perchenet</last_name>
    <email>loic.perchenet@actelion.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Arizona Pulmonary Specialists, LTD</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85012</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeremy Feldman</last_name>
      <email>jpfeldman1@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UCSD Health Sciences</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Poch</last_name>
      <phone>858-657-7150</phone>
      <email>dspoch@ucsd.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UCLA Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rajan Saggar</last_name>
      <phone>310-267-7492</phone>
      <email>rsaggar@mednet.ucla.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic Jacksonville</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charles Burger</last_name>
      <phone>904-953-2381</phone>
      <email>burger.charles@mayo.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Florida</name>
      <address>
        <city>Weston</city>
        <state>Florida</state>
        <zip>33331</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Franck Rahaghi</last_name>
      <phone>954-659-5450</phone>
      <email>rahaghf@ccf.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Piedmont Pulmonary and Critical Care Research</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miller</last_name>
      <phone>404-350-0009</phone>
      <email>chad.miller@piedmont.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hector Cajigas</last_name>
      <phone>312-926-7755</phone>
      <email>hcajigas@northwestern.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Iowa Hospitals &amp; Clinics</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Cadaret</last_name>
      <phone>319-353-8117</phone>
      <email>linda-cadaret@uiowa.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kentuckiana Pulmonary Associates</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John McConnell</last_name>
      <phone>502-587-8000</phone>
      <email>Mcco3526@bellsouth.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of New Mexico Hospital</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lana Melendres-Groves</last_name>
      <phone>505-272-4751</phone>
      <email>lmelendres@salud.unm.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins School of Medicine</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Hassoun</last_name>
      <phone>410-614-6311</phone>
      <email>phassoun@jhmi.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tufts Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111-1552</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ioana Preston</last_name>
      <phone>617-636-4288</phone>
      <email>ipreston@tuftsmedicalcenter.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Boston University Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02118-2526</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elisabeth Klings</last_name>
      <phone>617-638-4860</phone>
      <email>klingon@bu.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Regents of the University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109-5853</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vallerie McLaughlin</last_name>
      <phone>734-938-5383</phone>
      <email>vmclaugh@umich.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Michigan</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Murali Chakinala</last_name>
      <phone>314-454-8766</phone>
      <email>mchakina@dom.wustl.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Christ Hospital</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219-2906</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Engel</last_name>
      <phone>513-244-9096</phone>
      <email>lindnermd@thechristhospital.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Allegheny General Hospital of Research</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raymond Benza</last_name>
      <phone>412-359-4760</phone>
      <email>rbenza@wpahs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UPMC Presbyterian</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Mathier</last_name>
      <phone>412-647-7168</phone>
      <email>mathierm@upmc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390-8550</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Chin</last_name>
      <phone>214-645-6491</phone>
      <email>kelly.chin@utsouthwestern.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Houston Methodist Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adaani Frost</last_name>
      <phone>713-441-7182</phone>
      <email>afrost@houstonmethodist.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Prince Albert Hospital</name>
      <address>
        <city>Camperdown</city>
        <state>New South Wales</state>
        <zip>2050</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Celermajer</last_name>
      <phone>+61 407 892217</phone>
      <email>david.celermajer@sswahs.nsw.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Vincents Hospital Sydney</name>
      <address>
        <city>Darlinghurst</city>
        <state>New South Wales</state>
        <zip>2010</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Keogh</last_name>
      <phone>+61 2 8382 2641</phone>
      <email>Anne.Keogh@svha.org.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Alfred Hospital</name>
      <address>
        <city>Melbourne</city>
        <zip>3004</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Trevor Williams</last_name>
      <phone>+61 3 9076 2405</phone>
      <email>t.williams@alfred.org.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>LKH -Universität Klinkum Graz</name>
      <address>
        <city>Graz</city>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Horst Olschewski</last_name>
      <phone>+ 43 316-385 12183</phone>
      <email>horst.olschewski@medunigraz.ac.at</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Krankenhaus der Elisabethinen Linz</name>
      <address>
        <city>Linz</city>
        <zip>4020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Regina Steringer-Maschenbauer</last_name>
      <phone>+43 732 7676 4916</phone>
      <email>Regina.Steringer-Mascherbauer@ordensklinikum.at</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>AKH Wien</name>
      <address>
        <city>Wien</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Irene Lange</last_name>
      <phone>+43 1 40 400 46 140</phone>
      <email>irene.lang@meduniwien.ac.at</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Erasme</name>
      <address>
        <city>Brussels</city>
        <zip>1070</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Luc Vachiéry</last_name>
      <phone>+32 (0)2 555 56 02</phone>
      <email>jeanluc.vachiery@erasme.ulb.ac.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UZ Leuven - Campus Gasthuisberg</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catharina Belge</last_name>
      <phone>+32 16 34 26 65</phone>
      <email>catharina.belge@uzleuven.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vancouver General Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V5Z 1M9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Swiston</last_name>
      <phone>+1 604-875-4111 ext. 69525</phone>
      <email>swiston@mail.ubc.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>London Health Sciences Centre - Victoria Hospital</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 5W9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sanjay Mehta</last_name>
      <phone>+1 519-667-6723</phone>
      <email>sanjay.mehta@lhsc.on.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Toronto</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2N2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Granton</last_name>
      <phone>+1 416 340 4800 8137</phone>
      <email>john.granton@uhn.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jewish General Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3T 1E2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Langleben</last_name>
      <phone>+1 514-340-7531</phone>
      <email>david.langleben@mcgill.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut Universitaire de Cardiologie et de Pneumologie de Québec</name>
      <address>
        <city>Quebec City</city>
        <state>Quebec</state>
        <zip>G1V 4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steve Provencher</last_name>
      <phone>+1 418-656-4747</phone>
      <email>steve.provencher@crhl.ulaval.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Calgary</name>
      <address>
        <city>Calgary</city>
        <zip>T1Y 6J4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Ottawa Heart Institute</name>
      <address>
        <city>Ottawa</city>
        <zip>K1Y 4W7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Marie Mielniczuk</last_name>
      <phone>613 696-7274</phone>
      <email>lmielniczuk@ottawaheart.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aarhus University Hospital Skejby</name>
      <address>
        <city>Aarhus</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jens Nielsen-Kudsk</last_name>
      <phone>+45 7845 2125</phone>
      <email>je.nielsen.kudsk@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rigshospitalet Copenhagen</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jorn Carlsen</last_name>
      <phone>+45 35 45 8060</phone>
      <email>joern.carlsen@regionh.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Bicêtre</name>
      <address>
        <city>Le Kremlin-Bicêtre</city>
        <zip>94270</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xavier Jaïs</last_name>
      <phone>+33 1 45 21 78 95</phone>
      <email>xavier.jais@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Unversitätsklinikum Carl Gustav Carus</name>
      <address>
        <city>Dresden</city>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Halank</last_name>
      <phone>+49 351 796 5624</phone>
      <email>michael.halank@uniklinikum-dresden.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Giessen</name>
      <address>
        <city>Giessen</city>
        <zip>35392</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ardeschir Ghofrani</last_name>
      <phone>+49 641 99 42422</phone>
      <email>ardeschir.ghofrani@innere.med.uni-giessen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hans Klose</last_name>
      <phone>+49 40 7410 54970</phone>
      <email>klose@uke.uni-hamburg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marius Hoepter</last_name>
      <phone>+49-511-532 3537</phone>
      <email>hoeper.marius@mh-hannover.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69126</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ekkehard Grünig</last_name>
      <phone>+49 6221 396 8053</phone>
      <email>ekkehard.gruenig@med.uni-heidelberg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Köln</name>
      <address>
        <city>Köln</city>
        <zip>50924</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephan Rosenkranz</last_name>
      <phone>+49 221 478 32 402</phone>
      <email>Stephan.Rosenkranz@uk-koeln.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Regensburg</name>
      <address>
        <city>Regensburg</city>
        <zip>93053</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tobias Lange</last_name>
      <phone>+49 941 9447281</phone>
      <email>tobias.lange@ukr.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Würzburg Mitte gGmbH</name>
      <address>
        <city>Würzburg</city>
        <zip>97074</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthias Held</last_name>
      <phone>+49 931 791 2811</phone>
      <email>matthias.held@missioklinik.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Missionsärztliche Klinik Würzburg</name>
      <address>
        <city>Würzburg</city>
        <zip>97074</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthias Held</last_name>
      <phone>+49 931 791 2811</phone>
      <email>matthias.held@missioklinik.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Sant'Orsola</name>
      <address>
        <city>Bologna</city>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nazzareno Galiè</last_name>
      <phone>+39 0516363536</phone>
      <email>nazzareno.galie@unibo.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ambulatorio Scompenso Cardiaco e Trapianti</name>
      <address>
        <city>Pavia</city>
        <zip>5021</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Scelsi</last_name>
      <phone>+39 0382 501326</phone>
      <email>l.scelsi@smatteo.pv.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>VUmc Amsterdam</name>
      <address>
        <city>Amsterdam</city>
        <zip>1081 HV</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bogaard Jan</last_name>
      <phone>+31 20 44 44444</phone>
      <email>hj.bogaard@vumc.nl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Maastricht University Medical Center</name>
      <address>
        <city>Maastricht</city>
        <zip>6229 HX</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pieter van Paassen</last_name>
      <phone>+31 433877548</phone>
      <email>p.van.paassen@mumc.nl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Erasmus Medical Center Rotterdam</name>
      <address>
        <city>Rotterdam</city>
        <zip>3015 CE</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karin Boomars</last_name>
      <phone>+31 10 703 12 63</phone>
      <email>k.boomars@erasmusmc.nl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Haukeland University hospital Bergen</name>
      <address>
        <city>Bergen</city>
        <zip>5021</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolai Johannessen</last_name>
      <phone>+47 55 97 50 00</phone>
      <email>nicolai.maroni.johannessen@helse-bergen.no</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Skånes universitetssjukhus Lund</name>
      <address>
        <city>Lund</city>
        <zip>221 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Göran Radegran</last_name>
      <phone>+46 46 171355</phone>
      <email>goran.radegran@skane.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Norrlands universitetssjukhus</name>
      <address>
        <city>Umeå</city>
        <zip>901 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Söderberg</last_name>
      <phone>+46 90 785 15 46</phone>
      <email>stefan.soderberg@medicin.umu.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kardiologkliniken</name>
      <address>
        <city>Uppsala</city>
        <zip>751 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gerhard Wikström</last_name>
      <phone>+46 18-611 00 00</phone>
      <email>Gerhard.Wikstrom@medsci.uu.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universiätsspital Zürich</name>
      <address>
        <city>Zürich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silvia Ulrich</last_name>
      <phone>+41 44 255 22 20</phone>
      <email>silvia.ulrich@usz.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Canada</country>
    <country>Denmark</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Norway</country>
    <country>Sweden</country>
    <country>Switzerland</country>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 22, 2015</study_first_submitted>
  <study_first_submitted_qc>September 22, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 23, 2015</study_first_posted>
  <last_update_submitted>May 2, 2018</last_update_submitted>
  <last_update_submitted_qc>May 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tadalafil</mesh_term>
    <mesh_term>Macitentan</mesh_term>
    <mesh_term>Selexipag</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

